A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)

PHASE4CompletedINTERVENTIONAL

Enrollment

420

Participants

Timeline

Start Date

September 14, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions

Uncomplicated Malaria

Interventions

DRUG

PQ supervised

DRUG

PQ unsupervised

Trial Locations (1)

Timika Research Facility, Timika

All Listed Sponsors

collaborator

Timika Research Facility Kompleks RSMM, Timika-Papua, Indonesia

UNKNOWN

lead

Menzies School of Health Research

OTHER

NCT02787070 - A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI) | Biotech Hunter | Biotech Hunter